Chemotherapy and Drug Information

Advanced thyroid cancer responds to targeted therapy with sunitinib

Sunitinib (Sutent), a drug approved for treatment of several other cancers, may be an effective adjunctive treatment for patients with advanced differentiated thyroid cancer.

Affect of chemotherapy on saliva test results

Affect of chemotherapy on saliva test results

Do cancer treatments alter alleles affecting saliva, thus rendering a Genecept Assay null and void?

Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure

Patients with larger malignant tumors of the breast who undergo chemotherapy before breast cancer surgery are more likely to opt for a breast-preserving procedure, according to a new study.

Combination therapy found best for low-grade brain tumors

New evidence indicates that combining chemotherapy with radiation therapy may be the best option for people with a low-grade form of brain cancer.

Algorithm increases surgical success in advanced ovarian cancer

A new surgical algorithm allows for greater percentage of visible tumor removal.

Chemotherapy after bladder cancer surgery improves survival

The addition of chemotherapy after bladder cancer surgery lowered risk of death by approximately 30%, over surgery alone, according to a study that reviewed patient data.

Drug sequence with gemcitabine

Drug sequence with gemcitabine

When giving gemcitabine (Gemzar) and cisplatin (Platinol), is it better to give gemcitabine first to reduce myelosuppression with every indication?

Androgen receptor abnormality may not affect response to chemotherapy

Study findings suggest that androgen receptor V7 (AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer.

FDA greenlights dinutuximab to treat high-risk neuroblastoma

FDA greenlights dinutuximab to treat high-risk neuroblastoma

First approval for a therapy aimed specifically to treat the rare pediatric cancer

Stat Consult Slideshows

Fluorouracil (5-FU)

This slideshow reviews fluorouracil (5-FU), indicated for palliative treatment of breast cancer, colorectal cancer, gastric cancer, and carcinoma of the pancreas; also adjuvant treatment of colorectal cancer.

Netupitant/Palonosetron (Akynzeo)

This slideshow reviews netupitant/palonosetron (Akynzeo), indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.

Bevacizumab (Avastin)

This slideshow reviews bevacizumab (Avastin), indicated for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in persistent, recurrent, or metastatic disease.

To view all content in our Stat Consult section, please click here.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs